AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 25, 2007). doi:10.1152/ajpendo.00444.2007
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
293/6/E1709    most recent
00444.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotronen, A.
Right arrow Articles by Yki-Jarvinen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotronen, A.
Right arrow Articles by Yki-Jarvinen, H.
Submitted on July 9, 2007
Accepted on September 21, 2007

EFFECT OF LIVER FAT ON INSULIN CLEARANCE

Anna Kotronen1*, Satu Vehkavaara2, Anneli Seppala-Lindroos3, Robert Bergholm4, and Hannele Yki-Jarvinen3

1 Department of Medicine, University of Helsinki, Helsinki, Finland; PO Box 700, Room C329b, Helsinki, 00029 HUCH, Finland; Minerva Medical Research Institute, Helsinki, Finland
2 Department of Medicine, University of Helsinki, Helsinki, Finland
3 Department of Medicine, University of Helsinki, Helsinki, Finland; Helsinki, Finland
4 Department of Medicine, University of Helsinki, Helsinki, Finland; Minerva Medical Research Institute, Helsinki, Finland

* To whom correspondence should be addressed. E-mail: anna.kotronen{at}helsinki.fi.

A fatty liver is associated with fasting hyperinsulinemia, which could reflect either impaired insulin clearance or hepatic insulin action. We determined the effect of liver fat (LFAT) on insulin clearance and hepatic insulin sensitivity in 80 non-diabetic subjects (age 43±1 yrs, BMI 26.3±0.5 kg/m2). Insulin clearance and hepatic insulin resistance were measured by the euglycemic hyperinsulinemic (insulin infusion rate 0.3 mU/kg·min for 240 min) clamp technique combined with the infusion of [3-3H]glucose, and liver fat by proton magnetic resonance spectroscopy. During hyperinsulinemia, both serum insulin concentrations and increments above basal remained approximately 40% higher (p<0.0001) in the high (15.0±1.5%) as com-pared to the low (1.8±0.2%) LFAT group independent of age, gender and BMI. Insulin clear-ance (ml/kgFFM·min) was inversely related to liver fat content (r=-0.52, p<0.0001) independent of age, gender and BMI (r=-0.37, p=0.001). The variation in insulin clearance due to that in liver fat (range 0-41%) explained on the average 27% of the variation in fS-insulin concentrations. The contribution of impaired insulin clearance to fS-insulin concentrations in-creased as a function of liver fat. This implies that indirect indexes of insulin sensitivity, such as HOMA, overestimate insulin resistance in subjects with high liver fat content. Liver fat content correlated significantly with fS-insulin concentrations adjusted for insulin clearance (r=0.43, p<0.0001), and with directly measured hepatic insulin sensitivity (r=-0.40, p=0.0002). We con-clude that increased liver fat is associated with both impaired insulin clearance and hepatic insu-lin resistance. Hepatic insulin sensitivity associates with liver fat content independent of insulin clearance.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.